Illumina ILMN Instruments — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Illumina in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Illumina's instruments — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Illumina's instruments — total revenue?
- Illumina (ILMN) reported instruments — total revenue of $120M in Q1 2026.
- How has Illumina's instruments — total revenue changed year-over-year?
- Illumina's instruments — total revenue increased by 7.1% year-over-year, from $112M to $120M.
- What is the long-term trend for Illumina's instruments — total revenue?
- Over 4 years (2021 to 2025), Illumina's instruments — total revenue has grown at a -10.5% compound annual growth rate (CAGR), from $752M to $482M.
- What does instruments — total revenue mean?
- This metric represents the total gross revenue generated from the sale of hardware and sequencing platforms within a specific business segment. It reflects the company's ability to drive adoption of its core technology infrastructure among life science and clinical research customers. Fluctuations in this figure indicate shifts in capital expenditure cycles for laboratory equipment and the overall market demand for high-throughput sequencing capabilities.